aid: veradermics
name: Veradermics
description: 'Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical
  company headquartered in New Haven, Connecticut, developing first-in-class therapeutics
  for common dermatologic and aesthetic conditions. Its lead program, VDPHL01, is an
  oral, non-hormonal candidate for pattern hair loss in men and women, in Phase II/III
  trials — the first oral pattern-hair-loss trials in nearly thirty years and the first
  US trials in female pattern hair loss. A broader pipeline targets alopecia, warts,
  molluscum contagiosum and atopic dermatitis. The company closed an oversubscribed
  $150M Series C in October 2025 and completed a US IPO in February 2026 under the
  ticker MANE. Veradermics operates no public developer program, developer portal, SDK
  or documented API; the only machine-readable surfaces on its corporate host are
  WordPress platform plumbing — an RFC 8414 / RFC 9728 OAuth discovery chain and an
  auth-gated MCP server registered by the WordPress MCP Adapter.'
image: https://veradermics.b-cdn.net/wp-content/uploads/2026/04/VERADERMICS-Website-OG-Option-1-2026APR23-V01-D.jpg
url: https://raw.githubusercontent.com/api-evangelist/veradermics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-09-02'
modified: '2026-09-02'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Healthcare
- Dermatology
- Clinical Trials
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.veradermics.com/
- type: TermsOfService
  url: https://www.veradermics.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.veradermics.com/privacy-policy/
- type: Support
  url: https://www.veradermics.com/contact-us/
- type: MCPServer
  url: mcp/veradermics-mcp.yml
- type: Authentication
  url: authentication/veradermics-authentication.yml
- type: OAuthScopes
  url: scopes/veradermics-scopes.yml
- type: WellKnown
  url: well-known/veradermics-well-known.yml
- type: Conformance
  url: conformance/veradermics-conformance.yml
- type: DomainSecurity
  url: security/veradermics-domain-security.yml
- type: LLMsTxt
  url: llms/veradermics-llms.txt
- type: Plans
  url: plans/veradermics-plans-pricing.yml
- type: RateLimits
  url: rate-limits/veradermics-rate-limits.yml
x-pointer-liveness:
  checked: '2026-09-02'
  probes:
  - url: https://www.veradermics.com/
    status: 200
  - url: https://www.veradermics.com/terms-of-use/
    status: 200
  - url: https://www.veradermics.com/privacy-policy/
    status: 200
  - url: https://www.veradermics.com/contact-us/
    status: 200
  removed:
  - url: https://forgeglobal.com/veradermics_stock/
    type: Website
    reason: >-
      Third-party secondary-market venue listing, not the company's own site — the
      "venue as Website" defect. Replaced with https://www.veradermics.com/. The Forge
      page itself answers 403 behind a Cloudflare bot challenge to automated clients.
    status: 403
x-enrichment:
  date: '2026-09-02'
  status: enriched
  artifacts_added: 11
  pass: local-v1